A new potent HIV-1 reverse transcriptase inhibitor. A synthetic peptide derived from the interface subunit domains
about
c-Src-dependent transcriptional activation of TFII-IERK1/2 regulates intracellular ATP levels through alpha-enolase expression in cardiomyocytes exposed to ischemic hypoxia and reoxygenationMetabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures.Transduction of the MPG-tagged fusion protein into mammalian cells and oocytes depends on amiloride-sensitive endocytic pathwayAnalysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.Integrating computational modeling and functional assays to decipher the structure-function relationship of influenza virus PB1 protein.Protein-protein interactions as targets for antiviral chemotherapy.Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules.Combining genetic and biochemical approaches to identify functional molecular contact points.Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptaseInhibition of HIV-1 reverse transcription: basic principles of drug action and resistance.Effective protein inhibition in intact mouse oocytes through peptide nanoparticle-mediated antibody transfection.Targeting the protein-protein interactions of the HIV lifecycle.Targeting human immunodeficiency virus type 1 assembly, maturation and budding.Allosteric modulation of protein oligomerization: an emerging approach to drug design.Computer applications for prediction of protein-protein interactions and rational drug design.Comparison of electroporation and Chariot™ for delivery of β-galactosidase into mammalian cells: strategies to use trehalose in cell preservation.Two independent regions of human telomerase reverse transcriptase are important for its oligomerization and telomerase activity.Homodimerization of the p51 subunit of HIV-1 reverse transcriptase.Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase.A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.Development of peptide inhibitors of HIV transmission.Interface Peptides
P2860
Q28213012-AC853363-8B4B-40B0-9555-7F84727785F8Q28909786-60B8A318-98CE-4EA3-97DE-F9AEC486BA2AQ33347477-F2444931-EE9C-4154-BDCD-B79D380282D8Q33496608-8CA5463A-932C-4987-B7CC-639666AAAF23Q33935269-967701E4-02AA-4C30-9932-94EA86858B0DQ34438247-836089A5-3A20-431E-9D86-75059D88A7FFQ34574076-3AFC174A-23E8-4FC9-8320-764404459B4FQ34747522-B2E9F044-A698-4697-BF47-E4C682EC0488Q34976859-949053C0-5F30-46EB-AEC9-7C75F804B1F4Q35070102-F07208EB-9864-484F-B32F-FB34904DB236Q35769639-F49C6419-E8E7-441D-A371-F4659B7068B1Q35917530-CCA31AB5-207D-4E35-9E32-DBD791B24870Q36826400-F25E3702-80FB-450E-9E5C-B37B28C62BFDQ37820252-A351BCD2-6E9A-4D2C-9192-459DC947F0D9Q37928913-7879C2FD-2595-4AA2-80DF-1897B4F46C02Q38208847-981841FA-4504-412A-BDC5-207E7B0F6630Q38364115-C9485A2B-3083-4119-BB18-FFF32FEA1199Q39616052-BB549CFA-A283-411D-83B9-9A98A5126B02Q40761812-DA182336-C56C-49E1-950F-7322F544DA61Q41500267-1CC270DE-A6F2-45DD-BD50-5982515EDC6EQ43774982-2699627C-558E-480C-A5AA-85C53D30D52DQ46295068-799FE984-0FC9-44BA-A123-C517DA274D65Q47576341-43E1C3D3-8AE3-4DE1-8DC4-FA945E38AA12Q55317261-FA3566D3-2C70-478C-BAB0-FCF085E41551Q57721879-89CBE1F4-6B49-4583-A1B1-C7632EDE59AF
P2860
A new potent HIV-1 reverse transcriptase inhibitor. A synthetic peptide derived from the interface subunit domains
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A new potent HIV-1 reverse tra ...... the interface subunit domains
@ast
A new potent HIV-1 reverse tra ...... the interface subunit domains
@en
A new potent HIV-1 reverse tra ...... the interface subunit domains
@nl
type
label
A new potent HIV-1 reverse tra ...... the interface subunit domains
@ast
A new potent HIV-1 reverse tra ...... the interface subunit domains
@en
A new potent HIV-1 reverse tra ...... the interface subunit domains
@nl
prefLabel
A new potent HIV-1 reverse tra ...... the interface subunit domains
@ast
A new potent HIV-1 reverse tra ...... the interface subunit domains
@en
A new potent HIV-1 reverse tra ...... the interface subunit domains
@nl
P2093
P2860
P3181
P356
P1476
A new potent HIV-1 reverse tra ...... the interface subunit domains
@en
P2093
M C Morris
V Robert-Hebmann
P2860
P304
P3181
P356
10.1074/JBC.274.35.24941
P407
P577
1999-08-27T00:00:00Z